Global CRISPR and CRISPR-Associated (Cas) Genes Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-crispr-n-crispr-associated-cas-genes-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The Global CRISPR and CRISPR-Associated (Cas) Genes Market Size was estimated at USD 1867.47 million in 2023 and is projected to reach USD 9833.81 million by 2029, exhibiting a CAGR of 31.90% during the forecast period.
This report provides a deep insight into the global CRISPR and CRISPR-Associated (Cas) Genes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CRISPR and CRISPR-Associated (Cas) Genes Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CRISPR and CRISPR-Associated (Cas) Genes market in any manner.
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Market Segmentation (by Type)
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market Segmentation (by Application)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CRISPR and CRISPR-Associated (Cas) Genes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The Global CRISPR and CRISPR-Associated (Cas) Genes Market Size was estimated at USD 1867.47 million in 2023 and is projected to reach USD 9833.81 million by 2029, exhibiting a CAGR of 31.90% during the forecast period.
This report provides a deep insight into the global CRISPR and CRISPR-Associated (Cas) Genes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CRISPR and CRISPR-Associated (Cas) Genes Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CRISPR and CRISPR-Associated (Cas) Genes market in any manner.
Global CRISPR and CRISPR-Associated (Cas) Genes Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Market Segmentation (by Type)
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market Segmentation (by Application)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market
- Overview of the regional outlook of the CRISPR and CRISPR-Associated (Cas) Genes Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CRISPR and CRISPR-Associated (Cas) Genes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CRISPR and CRISPR-Associated (Cas) Genes
1.2 Key Market Segments
1.2.1 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
1.2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET COMPETITIVE LANDSCAPE
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Manufacturers (2019-2024)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Manufacturers (2019-2024)
3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Sales Sites, Area Served, Product Type
3.6 CRISPR and CRISPR-Associated (Cas) Genes Market Competitive Situation and Trends
3.6.1 CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Rate
3.6.2 Global 5 and 10 Largest CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES INDUSTRY CHAIN ANALYSIS
4.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2019-2024)
6.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2019-2024)
6.4 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2019-2024)
7 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Sales by Application (2019-2024)
7.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) by Application (2019-2024)
7.4 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
8 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY REGION
8.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region
8.2 North America
8.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.1.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Editas Medicine
9.2.1 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.2.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.2.4 Editas Medicine Business Overview
9.2.5 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.2.6 Editas Medicine Recent Developments
9.3 Caribou Biosciences
9.3.1 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.3.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.3.5 Caribou Biosciences Business Overview
9.3.6 Caribou Biosciences Recent Developments
9.4 CRISPR therapeutics
9.4.1 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.4.2 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.4.4 CRISPR therapeutics Business Overview
9.4.5 CRISPR therapeutics Recent Developments
9.5 Intellia therapeutics, Inc.
9.5.1 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.5.4 Intellia therapeutics, Inc. Business Overview
9.5.5 Intellia therapeutics, Inc. Recent Developments
9.6 Cellectis
9.6.1 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.6.2 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.6.4 Cellectis Business Overview
9.6.5 Cellectis Recent Developments
9.7 Horizon Discovery Plc
9.7.1 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.7.2 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.7.4 Horizon Discovery Plc Business Overview
9.7.5 Horizon Discovery Plc Recent Developments
9.8 Sigma Aldrich
9.8.1 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.8.2 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.8.4 Sigma Aldrich Business Overview
9.8.5 Sigma Aldrich Recent Developments
9.9 Precision Biosciences
9.9.1 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.9.2 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.9.4 Precision Biosciences Business Overview
9.9.5 Precision Biosciences Recent Developments
9.10 Genscript
9.10.1 Genscript CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.10.2 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.10.4 Genscript Business Overview
9.10.5 Genscript Recent Developments
9.11 Sangamo Biosciences Inc.
9.11.1 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.11.4 Sangamo Biosciences Inc. Business Overview
9.11.5 Sangamo Biosciences Inc. Recent Developments
9.12 Lonza Group Limited
9.12.1 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.12.2 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.12.4 Lonza Group Limited Business Overview
9.12.5 Lonza Group Limited Recent Developments
9.13 Integrated DNA Technologies
9.13.1 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.13.2 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.13.4 Integrated DNA Technologies Business Overview
9.13.5 Integrated DNA Technologies Recent Developments
9.14 New England Biolabs
9.14.1 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.14.2 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.14.4 New England Biolabs Business Overview
9.14.5 New England Biolabs Recent Developments
9.15 Origene Technologies
9.15.1 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.15.2 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.15.4 Origene Technologies Business Overview
9.15.5 Origene Technologies Recent Developments
10 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET FORECAST BY REGION
10.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast
10.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country
10.2.3 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region
10.2.4 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CRISPR and CRISPR-Associated (Cas) Genes by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of CRISPR and CRISPR-Associated (Cas) Genes by Type (2025-2030)
11.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of CRISPR and CRISPR-Associated (Cas) Genes by Type (2025-2030)
11.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Application (2025-2030)
11.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Application
11.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CRISPR and CRISPR-Associated (Cas) Genes
1.2 Key Market Segments
1.2.1 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
1.2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET COMPETITIVE LANDSCAPE
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Manufacturers (2019-2024)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Manufacturers (2019-2024)
3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Sales Sites, Area Served, Product Type
3.6 CRISPR and CRISPR-Associated (Cas) Genes Market Competitive Situation and Trends
3.6.1 CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Rate
3.6.2 Global 5 and 10 Largest CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES INDUSTRY CHAIN ANALYSIS
4.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2019-2024)
6.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2019-2024)
6.4 Global CRISPR and CRISPR-Associated (Cas) Genes Price by Type (2019-2024)
7 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Sales by Application (2019-2024)
7.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) by Application (2019-2024)
7.4 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
8 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SEGMENTATION BY REGION
8.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region
8.2 North America
8.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.1.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Editas Medicine
9.2.1 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.2.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.2.4 Editas Medicine Business Overview
9.2.5 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.2.6 Editas Medicine Recent Developments
9.3 Caribou Biosciences
9.3.1 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.3.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
9.3.5 Caribou Biosciences Business Overview
9.3.6 Caribou Biosciences Recent Developments
9.4 CRISPR therapeutics
9.4.1 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.4.2 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.4.4 CRISPR therapeutics Business Overview
9.4.5 CRISPR therapeutics Recent Developments
9.5 Intellia therapeutics, Inc.
9.5.1 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.5.4 Intellia therapeutics, Inc. Business Overview
9.5.5 Intellia therapeutics, Inc. Recent Developments
9.6 Cellectis
9.6.1 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.6.2 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.6.4 Cellectis Business Overview
9.6.5 Cellectis Recent Developments
9.7 Horizon Discovery Plc
9.7.1 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.7.2 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.7.4 Horizon Discovery Plc Business Overview
9.7.5 Horizon Discovery Plc Recent Developments
9.8 Sigma Aldrich
9.8.1 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.8.2 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.8.4 Sigma Aldrich Business Overview
9.8.5 Sigma Aldrich Recent Developments
9.9 Precision Biosciences
9.9.1 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.9.2 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.9.4 Precision Biosciences Business Overview
9.9.5 Precision Biosciences Recent Developments
9.10 Genscript
9.10.1 Genscript CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.10.2 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.10.4 Genscript Business Overview
9.10.5 Genscript Recent Developments
9.11 Sangamo Biosciences Inc.
9.11.1 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.11.4 Sangamo Biosciences Inc. Business Overview
9.11.5 Sangamo Biosciences Inc. Recent Developments
9.12 Lonza Group Limited
9.12.1 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.12.2 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.12.4 Lonza Group Limited Business Overview
9.12.5 Lonza Group Limited Recent Developments
9.13 Integrated DNA Technologies
9.13.1 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.13.2 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.13.4 Integrated DNA Technologies Business Overview
9.13.5 Integrated DNA Technologies Recent Developments
9.14 New England Biolabs
9.14.1 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.14.2 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.14.4 New England Biolabs Business Overview
9.14.5 New England Biolabs Recent Developments
9.15 Origene Technologies
9.15.1 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
9.15.2 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
9.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Market Performance
9.15.4 Origene Technologies Business Overview
9.15.5 Origene Technologies Recent Developments
10 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET FORECAST BY REGION
10.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast
10.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country
10.2.3 Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region
10.2.4 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CRISPR and CRISPR-Associated (Cas) Genes by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of CRISPR and CRISPR-Associated (Cas) Genes by Type (2025-2030)
11.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of CRISPR and CRISPR-Associated (Cas) Genes by Type (2025-2030)
11.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Application (2025-2030)
11.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Application
11.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Region (M USD)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2022)
Table 10. Global Market CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Sales Sites and Area Served
Table 12. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Product Type
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CRISPR and CRISPR-Associated (Cas) Genes
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (K Units)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (M USD)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2019-2024)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2019-2024)
Table 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) by Type (2019-2024)
Table 27. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2024)
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2019-2024)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2024) & (K Units)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2019-2024)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2024) & (M USD)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2019-2024)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
Table 36. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 37. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2019-2024)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 41. South America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 43. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 44. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 45. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 50. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 51. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Editas Medicine Business Overview
Table 53. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 54. Editas Medicine Recent Developments
Table 55. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 56. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 57. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 59. Caribou Biosciences Business Overview
Table 60. Caribou Biosciences Recent Developments
Table 61. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 62. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 63. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. CRISPR therapeutics Business Overview
Table 65. CRISPR therapeutics Recent Developments
Table 66. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 67. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 68. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Intellia therapeutics, Inc. Business Overview
Table 70. Intellia therapeutics, Inc. Recent Developments
Table 71. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 72. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 73. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cellectis Business Overview
Table 75. Cellectis Recent Developments
Table 76. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 77. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 78. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Horizon Discovery Plc Business Overview
Table 80. Horizon Discovery Plc Recent Developments
Table 81. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 82. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 83. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sigma Aldrich Business Overview
Table 85. Sigma Aldrich Recent Developments
Table 86. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 87. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 88. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Precision Biosciences Business Overview
Table 90. Precision Biosciences Recent Developments
Table 91. Genscript CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 92. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 93. Genscript CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Genscript Business Overview
Table 95. Genscript Recent Developments
Table 96. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 97. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 98. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sangamo Biosciences Inc. Business Overview
Table 100. Sangamo Biosciences Inc. Recent Developments
Table 101. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 102. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 103. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Lonza Group Limited Business Overview
Table 105. Lonza Group Limited Recent Developments
Table 106. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 107. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 108. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Integrated DNA Technologies Business Overview
Table 110. Integrated DNA Technologies Recent Developments
Table 111. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 112. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 113. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. New England Biolabs Business Overview
Table 115. New England Biolabs Recent Developments
Table 116. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 117. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 118. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Origene Technologies Business Overview
Table 120. Origene Technologies Recent Developments
Table 121. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Region (M USD)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2022)
Table 10. Global Market CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Sales Sites and Area Served
Table 12. Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Product Type
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CRISPR and CRISPR-Associated (Cas) Genes
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (K Units)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (M USD)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Type (2019-2024)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2019-2024)
Table 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) by Type (2019-2024)
Table 27. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Type (2019-2024)
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Price (USD/Unit) by Type (2019-2024)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) by Application
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2024) & (K Units)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2019-2024)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2019-2024) & (M USD)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2019-2024)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
Table 36. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 37. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2019-2024)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 41. South America CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2019-2024) & (K Units)
Table 43. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 44. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 45. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 50. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 51. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Editas Medicine Business Overview
Table 53. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 54. Editas Medicine Recent Developments
Table 55. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 56. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 57. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes SWOT Analysis
Table 59. Caribou Biosciences Business Overview
Table 60. Caribou Biosciences Recent Developments
Table 61. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 62. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 63. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. CRISPR therapeutics Business Overview
Table 65. CRISPR therapeutics Recent Developments
Table 66. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 67. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 68. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Intellia therapeutics, Inc. Business Overview
Table 70. Intellia therapeutics, Inc. Recent Developments
Table 71. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 72. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 73. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cellectis Business Overview
Table 75. Cellectis Recent Developments
Table 76. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 77. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 78. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Horizon Discovery Plc Business Overview
Table 80. Horizon Discovery Plc Recent Developments
Table 81. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 82. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 83. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sigma Aldrich Business Overview
Table 85. Sigma Aldrich Recent Developments
Table 86. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 87. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 88. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Precision Biosciences Business Overview
Table 90. Precision Biosciences Recent Developments
Table 91. Genscript CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 92. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 93. Genscript CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Genscript Business Overview
Table 95. Genscript Recent Developments
Table 96. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 97. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 98. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sangamo Biosciences Inc. Business Overview
Table 100. Sangamo Biosciences Inc. Recent Developments
Table 101. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 102. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 103. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Lonza Group Limited Business Overview
Table 105. Lonza Group Limited Recent Developments
Table 106. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 107. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 108. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Integrated DNA Technologies Business Overview
Table 110. Integrated DNA Technologies Recent Developments
Table 111. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 112. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 113. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. New England Biolabs Business Overview
Table 115. New England Biolabs Recent Developments
Table 116. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Basic Information
Table 117. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Overview
Table 118. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Origene Technologies Business Overview
Table 120. Origene Technologies Recent Developments
Table 121. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global CRISPR and CRISPR-Associated (Cas) Genes Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CRISPR and CRISPR-Associated (Cas) Genes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD), 2019-2030
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) (2019-2030)
Figure 6. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (M USD)
Figure 11. CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Manufacturers in 2023
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers in 2023
Figure 13. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type
Figure 18. Sales Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type (2019-2024)
Figure 19. Sales Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type in 2023
Figure 20. Market Size Share of CRISPR and CRISPR-Associated (Cas) Genes by Type (2019-2024)
Figure 21. Market Size Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application
Figure 24. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2019-2024)
Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2023
Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2019-2024)
Figure 27. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application in 2023
Figure 28. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
Figure 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2019-2024)
Figure 30. North America CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 32. U.S. CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico CRISPR and CRISPR-Associated (Cas) Genes Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 37. Germany CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 43. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region in 2023
Figure 44. China CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 50. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 51. Brazil CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2025-2030)
Figure 65. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Application (2025-2030)
Figure 66. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of CRISPR and CRISPR-Associated (Cas) Genes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD), 2019-2030
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (M USD) (2019-2030)
Figure 6. Global CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (M USD)
Figure 11. CRISPR and CRISPR-Associated (Cas) Genes Sales Share by Manufacturers in 2023
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers in 2023
Figure 13. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CRISPR and CRISPR-Associated (Cas) Genes Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type
Figure 18. Sales Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type (2019-2024)
Figure 19. Sales Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type in 2023
Figure 20. Market Size Share of CRISPR and CRISPR-Associated (Cas) Genes by Type (2019-2024)
Figure 21. Market Size Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application
Figure 24. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2019-2024)
Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2023
Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2019-2024)
Figure 27. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application in 2023
Figure 28. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2019-2024)
Figure 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2019-2024)
Figure 30. North America CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 32. U.S. CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico CRISPR and CRISPR-Associated (Cas) Genes Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 37. Germany CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 43. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region in 2023
Figure 44. China CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 50. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2023
Figure 51. Brazil CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa CRISPR and CRISPR-Associated (Cas) Genes Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2025-2030)
Figure 65. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Application (2025-2030)
Figure 66. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2025-2030)